Interleukin-1B genotype modulates the improvement of coronary artery reactivity by lipid-lowering therapy with pravastatin: a placebo-controlled positron emission tomography study in young healthy men.

T Lehtimäki; R Laaksonen; T Janatuinen; R Vesalainen; P Nuutila; K Mattila; E Ilveskoski; M Luomala; P Saikku; J Knuuti; M Hurme

doi:10.1097/00008571-200310000-00007

Interleukin-1B genotype modulates the improvement of coronary artery reactivity by lipid-lowering therapy with pravastatin: a placebo-controlled positron emission tomography study in young healthy men.

T Lehtimäki
, R Laaksonen
, T Janatuinen
, R Vesalainen
, P Nuutila
, K Mattila
, E Ilveskoski
, M Luomala
, P Saikku
, J Knuuti
, M Hurme

Research output: Contribution to journal › Article › Scientific › peer-review

17 Citations (Scopus)

Original language	English
Pages (from-to)	633-639
Journal	Pharmacogenetics
Volume	13
Issue number	10
DOIs	https://doi.org/10.1097/00008571-200310000-00007
Publication status	Published - 2003
Publication type	A1 Journal article-refereed

Access to Document

10.1097/00008571-200310000-00007

Cite this

Lehtimäki, T., Laaksonen, R., Janatuinen, T., Vesalainen, R., Nuutila, P., Mattila, K., Ilveskoski, E., Luomala, M., Saikku, P., Knuuti, J., & Hurme, M. (2003). Interleukin-1B genotype modulates the improvement of coronary artery reactivity by lipid-lowering therapy with pravastatin: a placebo-controlled positron emission tomography study in young healthy men. Pharmacogenetics, 13(10), 633-639. https://doi.org/10.1097/00008571-200310000-00007

@article{37ba092d35884678bd9207a4cde9486a,

title = "Interleukin-1B genotype modulates the improvement of coronary artery reactivity by lipid-lowering therapy with pravastatin: a placebo-controlled positron emission tomography study in young healthy men.",

author = "T Lehtim{\"a}ki and R Laaksonen and T Janatuinen and R Vesalainen and P Nuutila and K Mattila and E Ilveskoski and M Luomala and P Saikku and J Knuuti and M Hurme",

year = "2003",

doi = "10.1097/00008571-200310000-00007",

language = "English",

volume = "13",

pages = "633--639",

number = "10",

}

Lehtimäki, T , Laaksonen, R, Janatuinen, T, Vesalainen, R, Nuutila, P, Mattila, K, Ilveskoski, E, Luomala, M, Saikku, P, Knuuti, J & Hurme, M 2003, 'Interleukin-1B genotype modulates the improvement of coronary artery reactivity by lipid-lowering therapy with pravastatin: a placebo-controlled positron emission tomography study in young healthy men.', Pharmacogenetics, vol. 13, no. 10, pp. 633-639. https://doi.org/10.1097/00008571-200310000-00007

Interleukin-1B genotype modulates the improvement of coronary artery reactivity by lipid-lowering therapy with pravastatin: a placebo-controlled positron emission tomography study in young healthy men. / Lehtimäki, T ; Laaksonen, R; Janatuinen, T et al.
In: Pharmacogenetics, Vol. 13, No. 10, 2003, p. 633-639.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Interleukin-1B genotype modulates the improvement of coronary artery reactivity by lipid-lowering therapy with pravastatin: a placebo-controlled positron emission tomography study in young healthy men.

AU - Lehtimäki, T

AU - Laaksonen, R

AU - Janatuinen, T

AU - Vesalainen, R

AU - Nuutila, P

AU - Mattila, K

AU - Ilveskoski, E

AU - Luomala, M

AU - Saikku, P

AU - Knuuti, J

AU - Hurme, M

PY - 2003

Y1 - 2003

U2 - 10.1097/00008571-200310000-00007

DO - 10.1097/00008571-200310000-00007

M3 - Article

SN - 0960-314X

VL - 13

SP - 633

EP - 639

JO - Pharmacogenetics

JF - Pharmacogenetics

IS - 10

ER -